Abstract
Background: Depression, anxiety and related disorders, including obsessive-compulsive disorders and trauma/stressor related disorders, have high prevalence, chronic courses and cause significant impairment. These disorders are also highly co-morbid, and appear to share etiology and maintenance factors. Recent developments have seen the emergence of transdiagnostic approaches that systematically address the common/shared features of these disorders. A key advantage of transdiagnostic approaches is that they can reduce the pressure on mental health professionals to be proficient in a plethora of single-disorder focused treatments. Currently almost all transdiagnostic approaches come from cognitive-behavioural therapy (CBT). However, not all clients prefer or benefit from CBT. Emotion-focused therapy (EFT) represents an evidence-based alternative to CBT. This study aims to examine a transdiagnostic adaptation of EFT (EFT-T) as a treatment for depression, anxiety and related disorders. Method: The current study is a randomised controlled trial that aims to establish the efficacy of EFT-T vs. wait-list control in the treatment of depression, anxiety and related disorders. Up to 40 clients presenting in a psychology/counselling service will be randomly assigned to two conditions: EFT-T (n=20) and wait-list control, with delayed intervention (n=20). Primary outcome measures will be the Overall Anxiety Severity and Impairment Symptoms, the Overall Depression Severity and Impairment Symptoms, and the Clinical Outcome in Routine Evaluation - Outcome Measure. Disorder specific self-report measures will also be used to assess the main symptomatology of respective primary diagnoses. Clients will be assessed prior to therapy, at week 16, at end of therapy, and at 6 months follow-up. Discussion: This study aims to provide an initial test of EFT-T as a transdiagnostic treatment for depression, anxiety and related disorders. It will provide estimates of effects sizes that can inform power calculations for a comparative trial, comparing EFT-T to a standard transdiagnostic treatment, CBT. Registration: ISRCTN11430110; registered on 07 January 2019.
Highlights
Over recent decades, the dominant paradigm in psychotherapeutic treatment has been disorder-specific treatment
This study aims to provide an initial test of Emotion-focused therapy (EFT)-T as a transdiagnostic treatment for depression, anxiety and related disorders
We propose that therapists extend therapy for up to an additional four sessions if (1) the client continues to be clinically distressed and (2) the client expresses an explicit wish to continue with therapy for this duration
Summary
The dominant paradigm in psychotherapeutic treatment has been disorder-specific treatment. A wide-range of evidence-based disorder-specific treatments have been developed to target depression, anxiety, and related disorders such as obsessive-compulsive disorder (OCD) and trauma/stressor related disorders (American Psychiatric Association [APA], 2013). The focus on developing interventions for these disorders is understandable Together they account for the majority of presentations typically seen in outpatient or primary care settings. Depression, anxiety and related disorders, including obsessive-compulsive disorders and trauma/stressor related disorders, have high prevalence, chronic courses and cause significant impairment. These disorders are highly co-morbid, and appear to share etiology and maintenance factors. Method: The current study is a randomised controlled trial that aims to establish the efficacy of EFT-T vs wait-list control in the treatment of depression, anxiety and related disorders. Clients will be assessed prior to therapy, at week 16, at end of therapy, and at 6 months follow-up
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
